{"hands_on_practices": [{"introduction": "Understanding the stringent response begins with its primary trigger: the ribosome. The ribosome-associated synthetase RelA is not activated constitutively but rather senses the status of amino acid availability during translation. This thought experiment uses well-characterized antibiotics as molecular probes to test your understanding of this activation mechanism, a common and powerful strategy in microbiology for dissecting cellular pathways [@problem_id:2539904].", "problem": "A ribosome-associated guanosine tetra- and penta-phosphate ((p)ppGpp) synthetase I (RelA) is activated on translating ribosomes when a deacylated transfer ribonucleic acid (tRNA) occupies the aminoacyl site (A-site) during amino acid starvation, initiating the stringent response in many bacteria such as Escherichia coli. In parallel, the bifunctional hydrolase/synthetase SpoT (SpoT) hydrolyzes (p)ppGpp and sets the steady-state alarmone level during balanced growth. Consider two antibiotics added at time $t=0$ to exponentially growing Escherichia coli with wild-type RelA and SpoT levels, during a short time window (minutes) in which protein abundances do not change appreciably:\n\n- Mupirocin, a specific inhibitor of isoleucyl-tRNA synthetase, and\n- Chloramphenicol, an inhibitor of peptidyl transfer at the ribosomal peptidyl transferase center.\n\nAssume the following foundational facts:\n- Translation elongation requires aminoacyl-tRNA accommodation into the A-site and peptide-bond formation.\n- Inhibition of an aminoacyl-tRNA synthetase reduces charging of the corresponding tRNA species and increases the cellular pool of deacylated tRNA for that amino acid.\n- RelA activation on the ribosome requires a deacylated tRNA accommodated in the A-site; an A-site occupied by an aminoacyl-tRNA does not activate RelA.\n- SpoT continuously hydrolyzes (p)ppGpp in vivo.\n\nWhich option best describes, for each antibiotic, the expected A-site occupancy state that is most relevant to RelA activation and the qualitative time course of cellular (p)ppGpp concentration $G(t)$ relative to the pre-drug baseline during continued drug exposure?\n\nA. Mupirocin: ribosomes stall at isoleucine codons with deacylated tRNA in the A-site, strongly activating RelA; $G(t)$ rises rapidly and approaches an elevated steady state. Chloramphenicol: ribosomes stall with an aminoacyl-tRNA accommodated in the A-site but peptide bond formation blocked, minimizing RelA activation; $G(t)$ decays toward a lower steady state due to ongoing hydrolysis.\n\nB. Mupirocin: ribosomes dissociate leaving the A-site empty, so RelA is not activated; $G(t)$ decreases. Chloramphenicol: deacylated tRNA accumulates in the A-site because peptide bond formation is blocked, strongly activating RelA; $G(t)$ rises to a higher steady state.\n\nC. Both mupirocin and chloramphenicol cause deacylated tRNA to occupy the A-site on most ribosomes; in both cases RelA is maximally activated and $G(t)$ increases similarly to a high steady state.\n\nD. Mupirocin: deacylated tRNA transiently occupies the A-site and briefly activates RelA, but SpoT rapidly returns $G(t)$ to its baseline even while drug is present. Chloramphenicol: aminoacyl-tRNA cannot bind the A-site, leaving it empty and weakly activating RelA; $G(t)$ remains near baseline.", "solution": "The problem statement will first be validated for scientific soundness, completeness, and objectivity.\n\n### Step 1: Extract Givens\n- **System**: Exponentially growing *Escherichia coli* with wild-type RelA and SpoT levels.\n- **Perturbation**: Two antibiotics are added at time $t=0$.\n- **Time Scale**: A short time window (minutes) in which protein abundances do not change appreciably.\n- **Antibiotic 1**: Mupirocin, a specific inhibitor of isoleucyl-tRNA synthetase.\n- **Antibiotic 2**: Chloramphenicol, an inhibitor of peptidyl transfer at the ribosomal peptidyl transferase center.\n- **Foundational Fact 1**: Translation elongation requires aminoacyl-tRNA accommodation into the A-site and peptide-bond formation.\n- **Foundational Fact 2**: Inhibition of an aminoacyl-tRNA synthetase reduces charging of the corresponding tRNA species and increases the cellular pool of deacylated tRNA for that amino acid.\n- **Foundational Fact 3**: RelA activation on the ribosome requires a deacylated tRNA accommodated in the A-site; an A-site occupied by an aminoacyl-tRNA does not activate RelA.\n- **Foundational Fact 4**: SpoT continuously hydrolyzes (p)ppGpp in vivo.\n- **Question**: Describe the A-site occupancy state relevant to RelA activation and the qualitative time course of cellular (p)ppGpp concentration, denoted $G(t)$, for each antibiotic.\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement is evaluated against the established criteria.\n\n- **Scientifically Grounded**: The problem is based on the canonical model of the stringent response in bacteria, a well-established and fundamental concept in microbiology. The mechanisms of action for both Mupirocin and Chloramphenicol are correctly described, as are the roles of RelA and SpoT in (p)ppGpp metabolism. All foundational facts are scientifically accurate.\n- **Well-Posed**: The problem sets up a clear \"before and after\" scenario with specific inhibitors. It asks for a qualitative prediction of the system's response, which is a standard and meaningful question in biology. The provided information is sufficient to deduce a unique outcome based on the given principles.\n- **Objective**: The language is technical, precise, and devoid of subjective or ambiguous terminology.\n\n### Step 3: Verdict and Action\nThe problem is valid. It is a standard, conceptually sound question in molecular microbiology. The solution will proceed by analyzing the effect of each antibiotic based on the provided facts.\n\n### Derivation of the Correct Answer\n\nThe cellular concentration of (p)ppGpp, $G(t)$, is governed by the net rate of its synthesis and hydrolysis. The rate of change can be expressed as:\n$$\n\\frac{dG(t)}{dt} = (\\text{Rate of Synthesis}) - (\\text{Rate of Hydrolysis})\n$$\nSynthesis is primarily carried out by RelA upon activation, with a smaller basal contribution from SpoT. Hydrolysis is carried out by SpoT.\n$$\n\\frac{dG(t)}{dt} = k_{\\text{synth,RelA}}[\\text{RelA}_{\\text{active}}] + k_{\\text{synth,SpoT}}[\\text{SpoT}] - k_{\\text{hydro,SpoT}}[\\text{SpoT}]\n$$\nBefore adding antibiotics (at $t < 0$), the system is in a steady state with a low baseline level of (p)ppGpp, meaning RelA is mostly inactive and the basal synthesis by SpoT is balanced by its hydrolysis. The key to the problem is to determine how each antibiotic affects the concentration of active RelA, $[\\text{RelA}_{\\text{active}}]$, which is proportional to the number of ribosomes with a deacylated tRNA in the A-site.\n\n**Case 1: Mupirocin Treatment**\n1.  Mupirocin specifically inhibits isoleucyl-tRNA synthetase.\n2.  Based on Foundational Fact 2, this causes the cellular pool of charged isoleucyl-tRNA to deplete and the pool of deacylated tRNA for isoleucine to increase.\n3.  During protein synthesis, when a ribosome encounters an isoleucine codon on an mRNA, it attempts to bind the corresponding aminoacyl-tRNA in its A-site.\n4.  Due to the scarcity of charged isoleucyl-tRNA, a deacylated tRNA for isoleucine will frequently occupy the A-site instead.\n5.  According to Foundational Fact 3, the presence of a deacylated tRNA in the A-site is the specific trigger for RelA activation.\n6.  The ribosome stalls, and the associated RelA protein begins to rapidly synthesize (p)ppGpp. This occurs across many actively translating ribosomes.\n7.  The rate of synthesis, particularly the term $k_{\\text{synth,RelA}}[\\text{RelA}_{\\text{active}}]$, increases dramatically and far outweighs the rate of hydrolysis by SpoT.\n8.  Consequently, $\\frac{dG(t)}{dt} > 0$, and the concentration of (p)ppGpp, $G(t)$, will rise sharply. It will approach a new, much higher steady-state level where synthesis and hydrolysis rates re-balance, limited by factors such as substrate availability or feedback on the enzymes.\n\n**Case 2: Chloramphenicol Treatment**\n1.  Chloramphenicol inhibits the peptidyl transferase center (PTC) of the ribosome.\n2.  Consider a ribosome during elongation. An aminoacyl-tRNA, corresponding to the codon in the A-site, successfully binds. This is the accommodation step (Foundational Fact 1). The cell is not starved for amino acids, so the pools of charged tRNAs are replete.\n3.  The next step, peptide bond formation, is catalyzed by the PTC. Chloramphenicol blocks this specific step.\n4.  The ribosome therefore stalls with a peptidyl-tRNA in its P-site and a correctly charged **aminoacyl-tRNA** in its A-site.\n5.  According to Foundational Fact 3, an A-site occupied by an aminoacyl-tRNA does not activate RelA.Thus, RelA remains largely inactive.\n6.  The rate of (p)ppGpp synthesis from RelA remains at its low, pre-drug level. The overall synthesis rate is dominated by the basal activity of SpoT.\n7.  However, according to Foundational Fact 4, SpoT continuously hydrolyzes (p)ppGpp. In the absence of RelA's massive synthetic activity, this ongoing hydrolysis becomes the dominant process affecting the (p)ppGpp pool.\n8.  Thus, $\\frac{dG(t)}{dt} < 0$. The concentration of (p)ppGpp, $G(t)$, will decay from its pre-drug baseline towards a new, lower steady state determined by the bifunctional activity of SpoT alone. This effect is known as the \"relaxed response\".\n\n### Option-by-Option Analysis\n\n**A. Mupirocin: ribosomes stall at isoleucine codons with deacylated tRNA in the A-site, strongly activating RelA; $G(t)$ rises rapidly and approaches an elevated steady state. Chloramphenicol: ribosomes stall with an aminoacyl-tRNA accommodated in the A-site but peptide bond formation blocked, minimizing RelA activation; $G(t)$ decays toward a lower steady state due to ongoing hydrolysis.**\n- This option accurately describes the outcome for both mupirocin and chloramphenicol, consistent with our derivation. The mechanism of stalling, the state of the A-site, the effect on RelA activation, and the resulting change in $G(t)$ are all correctly stated for each drug.\n- **Verdict: Correct.**\n\n**B. Mupirocin: ribosomes dissociate leaving the A-site empty, so RelA is not activated; $G(t)$ decreases. Chloramphenicol: deacylated tRNA accumulates in the A-site because peptide bond formation is blocked, strongly activating RelA; $G(t)$ rises to a higher steady state.**\n- The description for Mupirocin is incorrect. Ribosomes stall, they do not dissociate, and the A-site is occupied by deacylated tRNA, which *activates* RelA.\n- The description for Chloramphenicol is incorrect. It causes stalling with an *aminoacyl-tRNA* in the A-site, not a deacylated one, thus *preventing* RelA activation.\n- **Verdict: Incorrect.**\n\n**C. Both mupirocin and chloramphenicol cause deacylated tRNA to occupy the A-site on most ribosomes; in both cases RelA is maximally activated and $G(t)$ increases similarly to a high steady state.**\n- This statement is incorrect. It conflates the mechanisms of the two antibiotics. Chloramphenicol does not cause deacylated tRNA to occupy the A-site. Consequently, the effects on $G(t)$ are opposite, not similar.\n- **Verdict: Incorrect.**\n\n**D. Mupirocin: deacylated tRNA transiently occupies the A-site and briefly activates RelA, but SpoT rapidly returns $G(t)$ to its baseline even while drug is present. Chloramphenicol: aminoacyl-tRNA cannot bind the A-site, leaving it empty and weakly activating RelA; $G(t)$ remains near baseline.**\n- The description for Mupirocin is incorrect. With continuous drug presence, the starvation signal is continuous, not transient. The new high steady state is maintained as long as the drug is present. SpoT hydrolysis cannot overcome the massive RelA synthesis.\n- The description for Chloramphenicol is incorrect. Chloramphenicol does not block A-site binding; it blocks the step after binding. The ribosome stalls with a filled, not empty, A-site, leading to no RelA activation and a *decrease* in $G(t)$, not maintenance near baseline.\n- **Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "2539904"}, {"introduction": "Once the alarmone (p)ppGpp is synthesized, it orchestrates a massive reprogramming of the bacterial transcriptome. This is achieved by direct binding to its primary target, the RNA polymerase (RNAP), but the regulatory outcome is exquisitely promoter-specific. This quantitative exercise will guide you through a model that demonstrates how (p)ppGpp binding to different sites on RNAP can produce opposite effects—inhibition of stable RNA promoters and activation of amino acid biosynthesis promoters—which is the central physiological consequence of the stringent response [@problem_id:2539882].", "problem": "In bacteria, the stringent response is mediated by guanosine tetra- and pentaphosphate ((p)ppGpp), which binds to two distinct sites on RNA polymerase (RNAP; ribonucleic acid polymerase) to modulate promoter-specific transcription initiation. Consider an Escherichia coli RNAP with two independent, non-cooperative (p)ppGpp sites: site $1$ with dissociation constant $K_{d,1} = 30\\ \\mu\\mathrm{M}$ and site $2$ with dissociation constant $K_{d,2} = 150\\ \\mu\\mathrm{M}$. Assume simple $1{:}1$ binding at each site, thermodynamic equilibrium, and independence between sites. You will analyze the fractional occupancy of each site and predict promoter-specific activities of two classes of promoters: a ribosomal RNA promoter (rrn P1-like) and an amino acid biosynthesis promoter.\n\nStart from the following fundamental base:\n- The law of mass action for $1{:}1$ binding at equilibrium, and the definition of the dissociation constant $K_d$.\n- Basic probability for independent events.\n- Promoter activity as the expectation over RNAP states, where each RNAP state is weighted by a promoter-specific activity factor.\n\nRNAP can exist in four ligand-occupancy states: unbound at both sites $(0,0)$, bound at site $1$ only $(1,0)$, bound at site $2$ only $(0,1)$, and bound at both sites $(1,1)$. Let the promoter-specific activity factors for the ribosomal RNA promoter be $\\sigma^{\\mathrm{rrn}}_{00} = 1.0$, $\\sigma^{\\mathrm{rrn}}_{10} = 0.3$, $\\sigma^{\\mathrm{rrn}}_{01} = 0.6$, and $\\sigma^{\\mathrm{rrn}}_{11} = 0.2$, and for the amino acid biosynthesis promoter be $\\sigma^{\\mathrm{aa}}_{00} = 1.0$, $\\sigma^{\\mathrm{aa}}_{10} = 0.9$, $\\sigma^{\\mathrm{aa}}_{01} = 1.7$, and $\\sigma^{\\mathrm{aa}}_{11} = 1.6$. These values encode that ppGpp binding at site $1$ strongly represses ribosomal RNA initiation, whereas site $2$ promotes amino acid biosynthesis promoter initiation, with combined effects reflected in the $(1,1)$ state.\n\nTasks:\n- Using only first principles (law of mass action and probability), compute the fractional occupancy of site $1$ and site $2$ and the probabilities of each RNAP state $(0,0)$, $(1,0)$, $(0,1)$, $(1,1)$ at ppGpp concentrations $[L] = 50\\ \\mu\\mathrm{M}$, $200\\ \\mu\\mathrm{M}$, and $800\\ \\mu\\mathrm{M}$.\n- For each $[L]$, compute the normalized initiation rate (dimensionless) for each promoter as the expectation over RNAP states, that is, the weighted sum of state probabilities with the corresponding $\\sigma$ for that promoter.\n- Based on these calculations, predict how increasing $[L]$ modulates each promoter class.\n\nReport as your final numeric answer the fold-change ratio\n$$R = \\frac{A^{\\mathrm{aa}}([L] = 200\\ \\mu\\mathrm{M})}{A^{\\mathrm{rrn}}([L] = 200\\ \\mu\\mathrm{M})}$$\nrounded to four significant figures. Express your final answer as a unitless decimal (no units).", "solution": "The problem statement must first be validated for scientific soundness, consistency, and completeness.\n\nGivens extracted from the problem statement:\n- System: *Escherichia coli* RNA polymerase (RNAP) with two independent, non-cooperative (p)ppGpp binding sites.\n- Binding Site $1$: Dissociation constant $K_{d,1} = 30\\ \\mu\\mathrm{M}$.\n- Binding Site $2$: Dissociation constant $K_{d,2} = 150\\ \\mu\\mathrm{M}$.\n- Ligand: (p)ppGpp, denoted as $L$.\n- RNAP states: $(0,0)$ (unbound), $(1,0)$ (site $1$ bound), $(0,1)$ (site $2$ bound), $(1,1)$ (both sites bound).\n- Activity factors for ribosomal RNA promoter (rrn): $\\sigma^{\\mathrm{rrn}}_{00} = 1.0$, $\\sigma^{\\mathrm{rrn}}_{10} = 0.3$, $\\sigma^{\\mathrm{rrn}}_{01} = 0.6$, and $\\sigma^{\\mathrm{rrn}}_{11} = 0.2$.\n- Activity factors for amino acid biosynthesis promoter (aa): $\\sigma^{\\mathrm{aa}}_{00} = 1.0$, $\\sigma^{\\mathrm{aa}}_{10} = 0.9$, $\\sigma^{\\mathrm{aa}}_{01} = 1.7$, and $\\sigma^{\\mathrm{aa}}_{11} = 1.6$.\n- Ligand concentrations for analysis: $[L] = 50\\ \\mu\\mathrm{M}$, $200\\ \\mu\\mathrm{M}$, and $800\\ \\mu\\mathrm{M}$.\n- Fundamental principles to use: Law of mass action, probability for independent events, and promoter activity as an expectation over states.\n\nVerdict on validity:\nThe problem is valid. It is scientifically grounded in the established principles of molecular biology and reaction kinetics, specifically the stringent response in bacteria. The model presented, using independent binding sites and activity factors, is a standard and acceptable simplification for quantitative analysis. The problem is well-posed, providing all necessary constants and conditions ($K_d$ values, ligand concentrations, activity factors) to compute a unique solution. The language is objective and precise. The problem does not violate any criteria for invalidity; it is self-contained, consistent, and solvable via formal methods.\n\nSolution:\nThe fractional occupancy, $\\theta$, of a single binding site by a ligand $L$ at equilibrium is derived from the law of mass action. For a reaction $R + L \\rightleftharpoons RL$, where $R$ is the binding site, the dissociation constant is $K_d = \\frac{[R][L]}{[RL]}$. The total concentration of sites is $[R]_{\\text{total}} = [R] + [RL]$. Fractional occupancy is defined as $\\theta = \\frac{[RL]}{[R]_{\\text{total}}}$. By rearranging the $K_d$ expression to $[R] = \\frac{K_d[RL]}{[L]}$ and substituting into the expression for $[R]_{\\text{total}}$, we get $\\theta = \\frac{[RL]}{\\frac{K_d[RL]}{[L]} + [RL]} = \\frac{1}{\\frac{K_d}{[L]} + 1}$. This simplifies to the Hill-Langmuir equation:\n$$\n\\theta = \\frac{[L]}{[L] + K_d}\n$$\nThe fractional occupancy represents the probability that a single site is bound by the ligand.\nLet $\\theta_1$ and $\\theta_2$ be the fractional occupancies for site $1$ and site $2$, respectively.\n$$\n\\theta_1 = \\frac{[L]}{[L] + K_{d,1}} \\quad \\text{and} \\quad \\theta_2 = \\frac{[L]}{[L] + K_{d,2}}\n$$\nSince the two binding sites are independent, the probability of the RNAP being in one of the four possible states can be calculated by multiplying the probabilities for each individual site. The probability of site $i$ being unbound is $1 - \\theta_i$.\n- $P_{00}$ (unbound-unbound): $P(0,0) = (1-\\theta_1)(1-\\theta_2)$\n- $P_{10}$ (bound-unbound): $P(1,0) = \\theta_1(1-\\theta_2)$\n- $P_{01}$ (unbound-bound): $P(0,1) = (1-\\theta_1)\\theta_2$\n- $P_{11}$ (bound-bound): $P(1,1) = \\theta_1\\theta_2$\n\nThe normalized initiation rate, or activity $A$, for a given promoter is the weighted average of the activities of each state, where the weights are the probabilities of those states. For a generic promoter activity $\\sigma$, this is:\n$$\nA = P_{00}\\sigma_{00} + P_{10}\\sigma_{10} + P_{01}\\sigma_{01} + P_{11}\\sigma_{11}\n$$\nThe problem requires the calculation of the ratio $R = \\frac{A^{\\mathrm{aa}}}{A^{\\mathrm{rrn}}}$ at a specific ligand concentration of $[L] = 200\\ \\mu\\mathrm{M}$. First, we calculate the fractional occupancies at this concentration, using $K_{d,1} = 30\\ \\mu\\mathrm{M}$ and $K_{d,2} = 150\\ \\mu\\mathrm{M}$.\n$$\n\\theta_1 = \\frac{200}{200 + 30} = \\frac{200}{230} = \\frac{20}{23}\n$$\n$$\n\\theta_2 = \\frac{200}{200 + 150} = \\frac{200}{350} = \\frac{20}{35} = \\frac{4}{7}\n$$\nNext, we calculate the probabilities for the four states:\n$$\nP_{00} = (1 - \\frac{20}{23})(1 - \\frac{4}{7}) = (\\frac{3}{23})(\\frac{3}{7}) = \\frac{9}{161}\n$$\n$$\nP_{10} = (\\frac{20}{23})(1 - \\frac{4}{7}) = (\\frac{20}{23})(\\frac{3}{7}) = \\frac{60}{161}\n$$\n$$\nP_{01} = (1 - \\frac{20}{23})(\\frac{4}{7}) = (\\frac{3}{23})(\\frac{4}{7}) = \\frac{12}{161}\n$$\n$$\nP_{11} = (\\frac{20}{23})(\\frac{4}{7}) = \\frac{80}{161}\n$$\nThe sum of probabilities is $\\frac{9+60+12+80}{161} = \\frac{161}{161} = 1$, which is correct.\n\nNow, we compute the activities for the rrn and aa promoters, $A^{\\mathrm{rrn}}([L] = 200\\ \\mu\\mathrm{M})$ and $A^{\\mathrm{aa}}([L] = 200\\ \\mu\\mathrm{M})$.\nFor the rrn promoter, with $\\sigma^{\\mathrm{rrn}}_{00} = 1.0$, $\\sigma^{\\mathrm{rrn}}_{10} = 0.3$, $\\sigma^{\\mathrm{rrn}}_{01} = 0.6$, and $\\sigma^{\\mathrm{rrn}}_{11} = 0.2$:\n$$\nA^{\\mathrm{rrn}}(200) = \\frac{9}{161}(1.0) + \\frac{60}{161}(0.3) + \\frac{12}{161}(0.6) + \\frac{80}{161}(0.2)\n$$\n$$\nA^{\\mathrm{rrn}}(200) = \\frac{1}{161}(9 + 18 + 7.2 + 16) = \\frac{50.2}{161}\n$$\nFor the aa promoter, with $\\sigma^{\\mathrm{aa}}_{00} = 1.0$, $\\sigma^{\\mathrm{aa}}_{10} = 0.9$, $\\sigma^{\\mathrm{aa}}_{01} = 1.7$, and $\\sigma^{\\mathrm{aa}}_{11} = 1.6$:\n$$\nA^{\\mathrm{aa}}(200) = \\frac{9}{161}(1.0) + \\frac{60}{161}(0.9) + \\frac{12}{161}(1.7) + \\frac{80}{161}(1.6)\n$$\n$$\nA^{\\mathrm{aa}}(200) = \\frac{1}{161}(9 + 54 + 20.4 + 128) = \\frac{211.4}{161}\n$$\nTo analyze the modulation by $[L]$, one would repeat these calculations for $[L]=50\\ \\mu\\mathrm{M}$ and $[L]=800\\ \\mu\\mathrm{M}$. This would show that $A^{\\mathrm{rrn}}$ decreases as $[L]$ increases (from $0.509$ at $50\\ \\mu\\mathrm{M}$ to $0.232$ at $800\\ \\mu\\mathrm{M}$), indicating repression. Conversely, $A^{\\mathrm{aa}}$ increases as $[L]$ increases (from $1.113$ at $50\\ \\mu\\mathrm{M}$ to $1.493$ at $800\\ \\mu\\mathrm{M}$), indicating activation. This behavior is consistent with the biological role of the stringent response.\n\nThe final task is to compute the ratio $R$:\n$$\nR = \\frac{A^{\\mathrm{aa}}(200)}{A^{\\mathrm{rrn}}(200)} = \\frac{211.4/161}{50.2/161} = \\frac{211.4}{50.2}\n$$\n$$\nR \\approx 4.211155378...\n$$\nRounding to four significant figures, the result is $4.211$.", "answer": "$$\\boxed{4.211}$$", "id": "2539882"}, {"introduction": "Connecting theoretical models of cellular regulation to biological reality requires the ability to accurately measure the molecules involved. Quantifying metabolites like (p)ppGpp is a non-trivial task that demands a rigorous experimental and analytical workflow, often employing techniques like Liquid Chromatography-Mass Spectrometry (LC-MS). This practical problem simulates the data analysis pipeline for a real metabolomics experiment, challenging you to convert raw instrument data into a meaningful biological quantity—the absolute intracellular concentration—a critical skill for any quantitative biologist [@problem_id:2539920].", "problem": "A bacterial culture is subjected to amino acid starvation, triggering the stringent response and accumulation of guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp). You harvest a pellet of $2.0 \\times 10^{9}$ Escherichia coli cells and quench/extract intracellular nucleotides into $1.00 \\ \\mathrm{mL}$ of $60 \\%$ methanol at $-20 \\ ^{\\circ}\\mathrm{C}$. From the extract, you take $100.0 \\ \\mu\\mathrm{L}$ and dilute to $1.000 \\ \\mathrm{mL}$ with water. You inject $5.00 \\ \\mu\\mathrm{L}$ of this diluted sample onto a Liquid Chromatography–Mass Spectrometry (LC–MS) system.\n\nExternal calibration (solvent standards) for each analyte provides a linear response of peak area $A$ versus on-column amount $n$ (in femtomoles, $\\mathrm{fmol}$) of the form $A = S \\, n + b$, where $S$ is the slope and $b$ is the intercept. The analyte-specific parameters and measured areas are:\n\n- ppGpp calibration: $S_{\\mathrm{ppGpp}} = 1.20 \\times 10^{5} \\ \\mathrm{area/fmol}$, $b_{\\mathrm{ppGpp}} = 1.50 \\times 10^{3}$.\n- pppGpp calibration: $S_{\\mathrm{pppGpp}} = 1.00 \\times 10^{5} \\ \\mathrm{area/fmol}$, $b_{\\mathrm{pppGpp}} = 2.00 \\times 10^{3}$.\n\n- Sample injection peak areas: $A_{\\mathrm{ppGpp}}^{\\mathrm{sample}} = 3.60 \\times 10^{6}$, $A_{\\mathrm{pppGpp}}^{\\mathrm{sample}} = 1.80 \\times 10^{6}$.\n- Procedural blank (no cells, processed identically) injection peak areas: $A_{\\mathrm{ppGpp}}^{\\mathrm{blank}} = 6.00 \\times 10^{4}$, $A_{\\mathrm{pppGpp}}^{\\mathrm{blank}} = 3.00 \\times 10^{4}$.\n\nIndependent spike-recovery experiments determine extraction recoveries (fraction of intracellular analyte recovered into the extract) of $R_{\\mathrm{ppGpp}} = 0.62$ and $R_{\\mathrm{pppGpp}} = 0.54$. Assume negligible losses other than these recoveries and negligible degradation during processing. The average intracellular cytoplasmic volume per cell is $0.60 \\ \\mathrm{fL}$.\n\nStarting from fundamental definitions of mass balance, linear calibration, and molar concentration $c = n/V$, compute the absolute total intracellular concentration of $(\\mathrm{p})\\mathrm{ppGpp}$, defined as ppGpp plus pppGpp, in the harvested cell population, after correcting for procedural blank, dilution, injection fraction, extract scaling, and extraction recovery. Express your final answer in micromolar. Round your answer to four significant figures.", "solution": "The problem as stated is scientifically grounded, well-posed, and objective. It describes a standard quantitative metabolomics workflow and provides all necessary data for a unique solution. The values given are plausible for an LC-MS experiment on bacterial cells undergoing the stringent response. Thus, we proceed with the solution.\n\nThe objective is to calculate the total intracellular concentration of (p)ppGpp, which is the sum of the concentrations of ppGpp and pppGpp:\n$$[(\\text{p)ppGpp}]_{\\text{total}} = [\\text{ppGpp}] + [\\text{pppGpp}]$$\nWe will calculate the intracellular concentration for each analyte, denoted by a generic subscript $X$, and then sum the results. The calculation proceeds by a series of back-calculations, starting from the measured peak area and accounting for all experimental steps.\n\nFirst, we define all given parameters in symbolic form:\nNumber of cells: $N_{\\text{cells}} = 2.0 \\times 10^{9}$\nInitial extraction volume: $V_{\\text{extract}} = 1.00 \\ \\mathrm{mL} = 1000 \\ \\mu\\mathrm{L}$\nAliquot volume for dilution: $V_{\\text{aliquot}} = 100.0 \\ \\mu\\mathrm{L}$\nFinal diluted volume: $V_{\\text{diluted}} = 1.000 \\ \\mathrm{mL} = 1000 \\ \\mu\\mathrm{L}$\nInjection volume: $V_{\\text{inject}} = 5.00 \\ \\mu\\mathrm{L}$\nAverage cell volume: $V_{\\text{cell}} = 0.60 \\ \\mathrm{fL}$\nCalibration relation: $A = S \\, n + b$\n\nParameters for ppGpp ($X = \\text{ppGpp}$):\n$S_{\\mathrm{ppGpp}} = 1.20 \\times 10^{5}$\n$A_{\\mathrm{ppGpp}}^{\\mathrm{sample}} = 3.60 \\times 10^{6}$\n$A_{\\mathrm{ppGpp}}^{\\mathrm{blank}} = 6.00 \\times 10^{4}$\n$R_{\\mathrm{ppGpp}} = 0.62$\n(Note: the intercept $b$ is implicitly handled by blank subtraction and is not directly used in the final calculation).\n\nParameters for pppGpp ($X = \\text{pppGpp}$):\n$S_{\\mathrm{pppGpp}} = 1.00 \\times 10^{5}$\n$A_{\\mathrm{pppGpp}}^{\\mathrm{sample}} = 1.80 \\times 10^{6}$\n$A_{\\mathrm{pppGpp}}^{\\mathrm{blank}} = 3.00 \\times 10^{4}$\n$R_{\\mathrm{pppGpp}} = 0.54$\n\nThe total intracellular volume of the cell pellet is:\n$$V_{\\text{total\\_cells}} = N_{\\text{cells}} \\times V_{\\text{cell}} = (2.0 \\times 10^{9}) \\times (0.60 \\ \\mathrm{fL}) = 1.2 \\times 10^{9} \\ \\mathrm{fL}$$\n\nThe logical steps to determine the concentration of analyte $X$ are as follows:\n\n1.  Calculate the amount of analyte injected onto the LC-MS column, $n_{X}^{\\text{on-column}}$, originating from the cells. This is achieved by subtracting the blank signal from the sample signal and using the calibration slope $S_X$. The instrument response is $A = S \\cdot n + b$. The blank-corrected signal corresponds to the amount of analyte derived from the sample, so $A_X^{\\text{sample}} - A_X^{\\text{blank}} = S_X \\cdot n_{X}^{\\text{on-column}}$.\n    $$n_{X}^{\\text{on-column}} = \\frac{A_{X}^{\\text{sample}} - A_{X}^{\\text{blank}}}{S_{X}}$$\n\n2.  Scale this on-column amount to find the total amount in the $1.000 \\ \\mathrm{mL}$ diluted sample, $n_{X}^{\\text{diluted}}$. This accounts for the fraction of the diluted sample that was injected.\n    $$n_{X}^{\\text{diluted}} = n_{X}^{\\text{on-column}} \\times \\frac{V_{\\text{diluted}}}{V_{\\text{inject}}}$$\n\n3.  Scale this amount to find the total amount in the initial $1.00 \\ \\mathrm{mL}$ cell extract, $n_{X}^{\\text{extract}}$. This accounts for the dilution of the initial extract.\n    $$n_{X}^{\\text{extract}} = n_{X}^{\\text{diluted}} \\times \\frac{V_{\\text{extract}}}{V_{\\text{aliquot}}}$$\n\n4.  Correct for the extraction recovery, $R_{X}$, to find the total intracellular amount of the analyte in the entire cell pellet, $n_{X}^{\\text{total}}$.\n    $$n_{X}^{\\text{total}} = \\frac{n_{X}^{\\text{extract}}}{R_{X}}$$\n\n5.  Calculate the intracellular concentration, $[X]$, by dividing the total intracellular amount by the total intracellular volume.\n    $$[X] = \\frac{n_{X}^{\\text{total}}}{V_{\\text{total\\_cells}}}$$\n\nCombining these steps gives a general formula for the concentration of species $X$:\n$$[X] = \\frac{1}{R_X \\cdot V_{\\text{total\\_cells}}} \\times \\left( \\frac{A_{X}^{\\text{sample}} - A_{X}^{\\text{blank}}}{S_{X}} \\right) \\times \\left( \\frac{V_{\\text{diluted}}}{V_{\\text{inject}}} \\right) \\times \\left( \\frac{V_{\\text{extract}}}{V_{\\text{aliquot}}} \\right)$$\n\nNow, we apply this formula to each analyte.\n\n**Calculation for ppGpp:**\n$$n_{\\mathrm{ppGpp}}^{\\text{on-column}} = \\frac{3.60 \\times 10^{6} - 6.00 \\times 10^{4}}{1.20 \\times 10^{5}} = \\frac{3.54 \\times 10^{6}}{1.20 \\times 10^{5}} = 29.5 \\ \\mathrm{fmol}$$\n$$n_{\\mathrm{ppGpp}}^{\\text{total}} = \\frac{1}{0.62} \\times (29.5 \\ \\mathrm{fmol}) \\times \\left( \\frac{1000 \\ \\mu\\mathrm{L}}{5.00 \\ \\mu\\mathrm{L}} \\right) \\times \\left( \\frac{1000 \\ \\mu\\mathrm{L}}{100.0 \\ \\mu\\mathrm{L}} \\right)$$\n$$n_{\\mathrm{ppGpp}}^{\\text{total}} = \\frac{1}{0.62} \\times (29.5 \\ \\mathrm{fmol}) \\times (200) \\times (10) = \\frac{59000}{0.62} \\ \\mathrm{fmol} \\approx 95161.3 \\ \\mathrm{fmol}$$\n$$[\\text{ppGpp}] = \\frac{95161.3 \\ \\mathrm{fmol}}{1.2 \\times 10^{9} \\ \\mathrm{fL}} \\approx 7.9301 \\times 10^{-5} \\ \\mathrm{fmol/fL}$$\n\n**Calculation for pppGpp:**\n$$n_{\\mathrm{pppGpp}}^{\\text{on-column}} = \\frac{1.80 \\times 10^{6} - 3.00 \\times 10^{4}}{1.00 \\times 10^{5}} = \\frac{1.77 \\times 10^{6}}{1.00 \\times 10^{5}} = 17.7 \\ \\mathrm{fmol}$$\n$$n_{\\mathrm{pppGpp}}^{\\text{total}} = \\frac{1}{0.54} \\times (17.7 \\ \\mathrm{fmol}) \\times \\left( \\frac{1000 \\ \\mu\\mathrm{L}}{5.00 \\ \\mu\\mathrm{L}} \\right) \\times \\left( \\frac{1000 \\ \\mu\\mathrm{L}}{100.0 \\ \\mu\\mathrm{L}} \\right)$$\n$$n_{\\mathrm{pppGpp}}^{\\text{total}} = \\frac{1}{0.54} \\times (17.7 \\ \\mathrm{fmol}) \\times (200) \\times (10) = \\frac{35400}{0.54} \\ \\mathrm{fmol} \\approx 65555.6 \\ \\mathrm{fmol}$$\n$$[\\text{pppGpp}] = \\frac{65555.6 \\ \\mathrm{fmol}}{1.2 \\times 10^{9} \\ \\mathrm{fL}} \\approx 5.4630 \\times 10^{-5} \\ \\mathrm{fmol/fL}$$\n\nNow, we must convert the units from $\\mathrm{fmol/fL}$ to micromolar ($\\mu\\mathrm{M}$).\nBy definition, $1 \\ \\mathrm{fmol} = 10^{-15} \\ \\mathrm{mol}$ and $1 \\ \\mathrm{fL} = 10^{-15} \\ \\mathrm{L}$. Therefore:\n$$1 \\ \\mathrm{fmol/fL} = \\frac{1 \\times 10^{-15} \\ \\mathrm{mol}}{1 \\times 10^{-15} \\ \\mathrm{L}} = 1 \\ \\mathrm{mol/L} = 1 \\ \\mathrm{M}$$\nTo convert from Molar to micromolar, we multiply by $10^{6}$:\n$$[X]_{\\mu\\mathrm{M}} = [X]_{\\mathrm{fmol/fL}} \\times 10^6$$\nApplying this conversion:\n$$[\\text{ppGpp}] = (7.9301 \\times 10^{-5}) \\times 10^{6} \\ \\mu\\mathrm{M} = 79.301 \\ \\mu\\mathrm{M}$$\n$$[\\text{pppGpp}] = (5.4630 \\times 10^{-5}) \\times 10^{6} \\ \\mu\\mathrm{M} = 54.630 \\ \\mu\\mathrm{M}$$\n\nFinally, we sum the concentrations to find the total (p)ppGpp concentration:\n$$[(\\text{p)ppGpp}]_{\\text{total}} = [\\text{ppGpp}] + [\\text{pppGpp}] = 79.301 \\ \\mu\\mathrm{M} + 54.630 \\ \\mu\\mathrm{M} = 133.931 \\ \\mu\\mathrm{M}$$\n\nThe problem requires the answer to be rounded to four significant figures.\n$$[(\\text{p)ppGpp}]_{\\text{total}} \\approx 133.9 \\ \\mu\\mathrm{M}$$", "answer": "$$\\boxed{133.9}$$", "id": "2539920"}]}